XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 4,726,855 3,452,210 8,172,370 8,910,059
General and administrative 4,792,850 3,117,417 7,396,137 6,014,166
Stock-based compensation – general and administrative 1,165,595 1,020,998 2,366,676 1,925,602
Total Operating Expenses 10,685,300 7,590,625 17,935,183 16,849,827
Operating Loss (10,685,300) (7,590,625) (17,935,183) (16,849,827)
Other Income        
Interest income 303,275 29,571 517,824 63,553
Gain on sale of New Jersey net operating losses 3,585,689
Total Other Income 303,275 29,571 4,103,513 63,553
Loss before Income Taxes (10,382,025) (7,561,054) (13,831,670) (16,786,274)
Income tax expense 144,000 288,000
Net Loss $ (10,526,025) $ (7,561,054) $ (14,119,670) $ (16,786,274)
Net Loss Per Share - Basic and Diluted (in Dollars per share) $ (0.07) $ (0.05) $ (0.1) $ (0.11)
Weighted Average Common Shares Outstanding        
Basic and diluted (in Shares) 146,251,945 146,041,852 146,231,313 146,026,847